Literature DB >> 23406818

Acetate-free biofiltration reduces intradialytic hypotension: a European multicenter randomized controlled trial.

Nicola Tessitore1, Antonio Santoro, Giovanni Oliviero Panzetta, Volker Wizemann, Rafael Perez-Garcia, Jorge Martinez Ara, Bruno Perrone, William Mantovani, Albino Poli.   

Abstract

BACKGROUND: Intradialytic hypotension (IH) is a common complication of bicarbonate hemodialysis (BD) and contributes to the intolerance of dialysis and the high cardiovascular morbidity and mortality among dialysis patients, the risk of which can be contained by convective therapies. AIMS/
METHODS: To assess whether acetate-free biofiltration (AFB), a hemodiafiltration technique found to improve intradialytic cardiovascular stability in short-term studies, can influence long-term IH rates, predialysis systolic blood pressure (SBP), cardiovascular morbidity and mortality by comparison with BD, we analyzed data from a randomized controlled trial enrolling 371 new-to-dialysis patients, 194 on BD and 177 on AFB.
RESULTS: During a 3-year follow-up, AFB carried a significantly lower risk of IH (incidence rate ratio 0.60 (95% CI 0.53-0.68), p < 0.0001). SBP dropped on AFB (p = 0.01), while it did not change on BD. Cardiovascular morbidity and mortality were similar between AFB and BD.
CONCLUSION: AFB carries a lower long-term IH rate and reduces SBP by comparison with BD.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23406818     DOI: 10.1159/000346293

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  6 in total

1.  Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study.

Authors:  Valeria Cernaro; Silvia Lucisano; Valeria Canale; Annamaria Bruzzese; Daniela Caccamo; Giuseppe Costantino; Michele Buemi; Domenico Santoro
Journal:  J Nephrol       Date:  2017-04-11       Impact factor: 3.902

2.  Relationship between Hypotension and Cerebral Ischemia during Hemodialysis.

Authors:  Clare MacEwen; Sheera Sutherland; Jonathan Daly; Christopher Pugh; Lionel Tarassenko
Journal:  J Am Soc Nephrol       Date:  2017-03-07       Impact factor: 10.121

3.  [Intradialytic arterial hypotension in a patient on chronic hemodialysis revealing ante-hypophyseal insufficiency].

Authors:  Jaouad El Maghraoui; Hanane Ouahabi; Nadia Kabbali; Mohamed Arrayhani; Farida Ajdi; Tariq Sqalli Houssaini
Journal:  Pan Afr Med J       Date:  2016-05-11

4.  The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation.

Authors:  William B Smith; Sandy Gibson; George E Newman; Kendra S Hendon; Margarita Askelson; James Zhao; Jamil Hantash; Brigid Flanagan; John W Larkin; Len A Usvyat; Ravi I Thadhani; Franklin W Maddux
Journal:  BMC Nephrol       Date:  2017-08-29       Impact factor: 2.388

5.  Hemodynamic and Metabolic Tolerance of Acetate-Free Biofiltration in Mechanically Ventilated Critically Ill Patients: A Real-Life Study.

Authors:  Anna Gouin; Pierre Tailpied; Olivier Marion; Laurence Lavayssiere; Chloé Medrano; Marie-Béatrice Nogier; Bruno Seigneuric; Nassim Kamar; Olivier Cointault; Stanislas Faguer
Journal:  J Clin Med       Date:  2021-12-07       Impact factor: 4.241

Review 6.  The Nephrologist's Role in the Collaborative Multi-Specialist Network Taking Care of Patients with Diabetes on Maintenance Hemodialysis: An Overview.

Authors:  Giuseppe Cavallari; Elena Mancini
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.